Prakiraan volume dodolan Absci Corp (ABSI)
Absci is supported by an AI ecosystem for antibody synthesis tailored for the pharmaceutical industry. The company's revenue guidance confirms this potential, with the 0.00 metric serving as the target level. Demand for accelerated R&D minimizes the impact of economic cycles, although current financial health relies on external capital due to the launch phase of its partnerships.
Rincian analitis lan laporan data perusahaan Absci Corp (ABSI)
- kuotasi lan prakiraan analis:
- rincian kapitalisasi pasar:
- informasi kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Absci|ABSI - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Absci Corp.|ABSI - Tanggungan utang kumulatif perusahaan|Utang marang nilai buku Absci Corp|ABSI - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Absci|Rasio cepet absci.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ABSI - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Absci|ABSI - Pangali rega marang bathi|Pangali Forward P/E Absci Corporation|ABSI - Pangali PEG|Pangali EV/EBITDA Absci Corp|ABSI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Absci|ABSI - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan absci.com|ABSI - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Absci
- data pendapatan lan penerimaan dodolan:
Ringkesan analisis perusahaan:Absci ABSI
The market assesses the potential of Absci (ABSI) through the lens of biomedical development sustainability, where the trend of projected sales reveals the business's actual viability by benchmarking revenue growth rates against industry averages. This indicator captures hidden asset degradation, confirming the company's stability amid the sector's geopolitical neutrality, which characterizes these securities as a defensive asset with low risk of loss.
Pesaing langsung
Prakiraan volume dodolan VEEV|Prakiraan volume dodolan doximity.com (DOCS)|Prakiraan volume dodolan HQY (HealthEquity)|Waystar Health - Prakiraan pendapatan perusahaan|CRVL - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Privia Medical Group PRVA|HURN: Prakiraan volume dodolan|CERT - Dodolan mangsa ngarep perusahaan|OMCL (Omnicell) - Prakiraan volume dodolan|GoodRx Inc (GDRX) - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan SDGR (Schrödinger Inc.)|Prakiraan volume pendapatan perusahaan PHR|Omada Health Inc - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan EVH|HSTM - Prakiraan pendapatan perusahaan|Definitive Healthcare Corp (DH) - Volume dodolan mangsa ngarep perusahaan|CCSI: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Agilon Health Corp (AGL)|SY (So-Young International) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan NRC (National Research)|Prakiraan volume dodolan SPOK|Prakiraan volume dodolan OptimizeRx Corp (OPRX)|Prakiraan volume dodolan TBRG (CPSI)|Simulations Plus Inc. - Prakiraan pendapatan perusahaan|SOPH - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan healthcatalyst.com HCAT|CCLD: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan researchsolutions.com|DLHC (DLH Corp) - Prakiraan volume dodolan|OneMedNet Corp. (ONMD) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan SCNX|Prakiraan volume dodolan healthcaretriangle.com (HCTI)|Prakiraan volume dodolan ISPC (iSpecimen)|Bullfrog AI Holdings, Inc. - Prakiraan pendapatan perusahaan|WORX - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan MSP Recovery Corp MSPR|ICCT: Prakiraan volume dodolan|MEDS - Dodolan mangsa ngarep perusahaan|ORGS (Orgenesis) - Prakiraan volume dodolan|R1 RCM Inc (RCM) - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan SHCR (Sharecare, Inc)|Prakiraan volume pendapatan perusahaan STRM|Syra Health Corp. - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan AMEH|MODN - Prakiraan pendapatan perusahaan|NextGen Healthcare Inc (NXGN) - Volume dodolan mangsa ngarep perusahaan
